Attractive and repulsive residue fragments at the interface of SARS-CoV-2 and hACE2

被引:5
|
作者
Rodriguez, Jorge H. [1 ]
机构
[1] Purdue Univ, Dept Phys & Astron, Computat Biomol Phys Grp, W Lafayette, IN 47907 USA
关键词
RECEPTOR-BINDING DOMAIN; SPIKE; CORONAVIRUS; ACE2;
D O I
10.1038/s41598-021-91877-x
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The initial stages of SARS-CoV-2 coronavirus attachment to human cells are mediated by non-covalent interactions of viral spike (S) protein receptor binding domains (S-RBD) with human ACE2 receptors (hACE2). Structural characterization techniques, such as X-ray crystallography (XRC) and cryoelectron microscopy (cryo-EM), previously identified SARS-CoV-2 spike protein conformations and their surface residues in contact with hACE2. However, recent quantum-biochemical calculations on the structurally related S-RBD of SARS-CoV-1 identified some contact-residue fragments as intrinsically attractive and others as repulsive. This indicates that not all surface residues are equally important for hACE2 attachment. Here, using similar quantum-biochemical methods, we report some four-residue fragments (i.e quartets) of the SARS-CoV-2 S-RBD as intrinsically attractive towards hACE2 and, therefore, directly promoting host-virus non-covalent binding. Other fragments are found to be repulsive although involved in intermolecular recognition. By evaluation of their respective intermolecular interaction energies we found two hACE2 fragments that include contact residues (ASP30, LYS31, HIS34) and (ASP38, TYR41, GLN42), respectively, behaving as important SARS-CoV-2 attractors. LYS353 also promotes viral binding via several mechanisms including dispersion van der Waals forces. Similarly, among others, three SARS-CoV-2 S-RBD fragments that include residues (GLN498, THR500, ASN501), (GLU484, PHE486, ASN487) and (LYS417), respectively, were identified as hACE2 attractors. In addition, key hACE2 quartets identified as weakly-repulsive towards the S-RBD of SARS-CoV-1 were found strongly attractive towards SARS-CoV-2 explaining, in part, the stronger binding affinity of hACE2 towards the latter coronavirus. These findings may guide the development of synthetic antibodies or identify potential viral epitopes.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Functionalized protein microparticles targeting hACE2 as a novel preventive strategy for SARS-CoV-2 infection
    Li, Yujia
    Huang, Yike
    Zhu, Kehui
    Duan, Xiaoqiong
    Li, Shilin
    Xu, Min
    Yang, Chunhui
    Liu, Jiaxin
    Baeumler, Hans
    Yu, Pin
    Xie, He
    Li, Bin
    Cao, Ye
    Chen, Limin
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2023, 638
  • [32] Modeling SARS-CoV-2 Infection in Mice Using Lentiviral hACE2 Vectors Infers Two Modes of Immune Responses to SARS-CoV-2 Infection
    Katzman, Chaja
    Israely, Tomer
    Melamed, Sharon
    Politi, Boaz
    Sittner, Assa
    Yahalom-Ronen, Yfat
    Weiss, Shay
    Abu Rass, Reem
    Zamostiano, Rachel
    Bacharach, Eran
    Ehrlich, Marcelo
    Paran, Nir
    Nissim, Lior
    VIRUSES-BASEL, 2022, 14 (01):
  • [33] Fatal Neurodissemination and SARS-CoV-2 Tropism in K18-hACE2 Mice Is Only Partially Dependent on hACE2 Expression
    Carossino, Mariano
    Kenney, Devin
    O'Connell, Aoife K.
    Montanaro, Paige
    Tseng, Anna E.
    Gertje, Hans P.
    Grosz, Kyle A.
    Ericsson, Maria
    Huber, Bertrand R.
    Kurnick, Susanna A.
    Subramaniam, Saravanan
    Kirkland, Thomas A.
    Walker, Joel R.
    Francis, Kevin P.
    Klose, Alexander D.
    Paragas, Neal
    Bosmann, Markus
    Saeed, Mohsan
    Balasuriya, Udeni B. R.
    Douam, Florian
    Crossland, Nicholas A.
    VIRUSES-BASEL, 2022, 14 (03):
  • [34] SARS-CoV-2 infection induces thymic atrophy mediated by IFN-γ in hACE2 transgenic mice
    Rizvi, Zaigham Abbas
    Sadhu, Srikanth
    Dandotiya, Jyotsna
    Sharma, Puja
    Binayke, Akshay
    Singh, Virendra
    Das, Vinayaka
    Khatri, Ritika
    Kumar, Rajesh
    Samal, Sweety
    Kalia, Manjula
    Awasthi, Amit
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 (07)
  • [35] A novel hACE2 knock-in mouse model recapitulates pulmonary and intestinal SARS-CoV-2 infection
    Zhou, Xiaoyang
    Sun, Weiyang
    Zhang, Yu
    Gu, Hongjing
    Wang, Ruixuan
    Xie, Peng
    Zhu, Yunkai
    Qiu, Minyue
    Ding, Xiaoyan
    Wang, Hui
    Gao, Yuwei
    Li, Jintao
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [36] A mouse model for SARS-CoV-2 infection by exogenous delivery of hACE2 using alphavirus replicon particles
    Zhang, Ya-Nan
    Li, Xiao-Dan
    Zhang, Zhe-Rui
    Zhang, Hong-Qing
    Li, Na
    Liu, Jing
    Li, Jia-Qi
    Zhang, Hua-Jun
    Wang, Ze-Jun
    Shen, Shuo
    Shi, Zheng-Li
    Wei, Hong-Ping
    Yuan, Zhi-Ming
    Ye, Han-Qing
    Zhang, Bo
    CELL RESEARCH, 2020, 30 (11) : 1046 - 1048
  • [37] Lucidenic acid A inhibits the binding of hACE2 receptor with spike protein to prevent SARS-CoV-2 invasion
    Xu, Juan
    Yang, WenTao
    Pan, YiFeng
    Xu, HaiShun
    He, Liang
    Zheng, BingSong
    Xie, YingQiu
    Wu, XueQian
    FOOD AND CHEMICAL TOXICOLOGY, 2022, 169
  • [38] Generation of a humanized mAce2 and a conditional hACE2 mouse models permissive to SARS-COV-2 infection
    Song, I-Wen
    Washington, Megan
    Leynes, Carolina
    Hsu, Jason
    Rayavara, Kempaiah
    Bae, Yangjin
    Haelterman, Nele
    Chen, Yuqing
    Jiang, Ming-Ming
    Drelich, Aleksandra
    Tat, Vivian
    Lanza, Denise G.
    Lorenzo, Isabel
    Heaney, Jason D.
    Tseng, Chien-Te Kent
    Lee, Brendan
    Marom, Ronit
    MAMMALIAN GENOME, 2024, 35 (02) : 113 - 121
  • [39] Rapid, reliable, and reproducible cell fusion assay to quantify SARS-Cov-2 spike interaction with hACE2
    Zhao, Min
    Su, Pei-Yi
    Castro, Danielle A.
    Tripler, Therese N.
    Hu, Yingxia
    Cook, Matthew
    Ko, Albert, I
    Farhadian, Shelli F.
    Israelow, Benjamin
    Dela Cruz, Charles S.
    Xiong, Yong
    Sutton, Richard E.
    PLOS PATHOGENS, 2021, 17 (06)
  • [40] Establishment and characterization of an hACE2/hTMPRSS2 knock-in mouse model to study SARS-CoV-2
    Liu, Hongwei
    Brostoff, Terza
    Ramirez, Ana
    Wong, Talia
    Rowland, Douglas J.
    Heffner, Mollie
    Flores, Arturo
    Willis, Brandon
    Evans, Jeffrey J.
    Lanoue, Louise
    Lloyd, K. C. Kent
    Coffey, Lark L.
    FRONTIERS IN IMMUNOLOGY, 2024, 15